CDC found cannabis in 42.7 percent of adolescent overdose deaths, but detection doesn't prove causation.

Cannabis and alcohol intoxication may delay opioid overdose recognition, a 911 call, or reversal with Narcan.

Adolescent cannabis use may signal access to other drugs, polysubstance experimentation, and overdose risk.

Teen cannabis use can open family conversations about street pills, fentanyl, vaping, alcohol, and naloxone.

On September 3, 2026, CDC investigators reported that cannabis was detected in 21 percent of 209,166 overdose deaths from January 2021 to June 2025 in 31 states and the District of Columbia. But the adolescent finding was more startling. Among 12- to 17-year-olds who died of an overdose, cannabis was identified in 42.7 percent of cases—the highest percentage of any age group. In almost 9 of 10 cannabis-positive adolescent deaths, fentanyl was involved. The trend was more alarming. The most recent six-month data (January–June 2025) reported that cannabis was detected in 44.6 percent of overdose deaths in adolescents ages 12–17—up from 35.9 percent in 2024.

What do these statistics indicate?

“This new CDC report stresses the importance of more highly prioritizing community-based approaches to preventing cannabis use among youth, as it may be a major clue to more extensive polydrug use and risk-taking in teens,” said General Barrye L. Price, president and CEO of Community Anti-Drug Coalitions of America (CADCA).

Despite the CDC’s cannabis finding, fentanyl remains the principal lethal engine driving overdose deaths, and fentanyl certainly can kill without any help from cannabis. But this doesn’t mean THC (the intoxicating substance in cannabis) doesn't matter.

THC may interfere with timely recognition and rescue. Whether plant-derived THC also increases fentanyl-related respiratory depression remains unknown. Alcohol, however, can directly worsen opioid-related sedation and respiratory depression.

Why the Adolescent Signal Matters

Earlier CDC research found 83.9 percent of overdose deaths among people ages 10-19 had involved illegally manufactured fentanyl. But few of these young people, only 35 percent, had a documented history of opioid use. Not surprisingly, nearly one-quarter showed evidence of counterfeit pill use.

Most adolescents were not shopping for fentanyl. Instead, they believed they were buying oxycodone, Xanax, or another familiar-looking pill that was primarily composed of fentanyl. As the DEA campaign warns, “One Pill Can Kill.” Today, experimentation may be fatal well before an opioid use disorder ever has time to develop.

The adolescent brain is still under construction, and considerable evidence suggests THC can........

© Psychology Today